Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage
pharmaceutical company focused on the discovery, development and
commercialization of first-in-class therapies for the treatment of
patients with glaucoma and other diseases of the eye, announced today
the acceleration of the expected timeline for reporting efficacy results
from the Company’s 400-patient Phase 3 registration trial (“Rocket 1”)
of Rhopressa TM , a novel once-daily, triple-action eye drop
being tested for its ability to lower intraocular pressure (IOP) in
patients with glaucoma or ocular hypertension.
Sign-up for Southwestern Energy Commences Offering Of 20,260,000 Shares Of Common Stock And 26,000,000 Depositary Shares Representing An Interest In Mandatory Convertible Preferred Stock investment picks
Paycom Software, Inc. (NYSE:PAYC) (the “Company”) announced today that
it has commenced a roadshow to market shares of its common stock to be
sold by certain selling stockholders in connection with a proposed
By Marta Falconi
ZURICH--Swiss biotech company AC Immune said on Monday it had struck a deal potentially worth $509 million with a unit of Johnson & Johnson (JNJ) to develop vaccines against Alzheimer's disease, the most common form of dementia.
Family Dollar Stores, Inc. (NYSE:FDO), a leading national discount
retailer offering name brands and quality, private brand merchandise,
has published a letter from CEO Howard Levine to the stockholders of
Family Dollar that explains the recommendation of the Board of Directors
that stockholders vote ‘FOR’ the merger with Dollar Tree (NASDAQ:DLTR).
The letter provides transparency on new feedback from the Federal Trade
Commission (“FTC”) staff about both the Dollar General proposal and the
Dollar Tree merger and details on a recent letter from the CEO of Dollar
Tree, and updates the compelling rationale for, and the substantial and
certain value Family Dollar stockholders will receive from, the Dollar
By Barbara Kollmeyer, MarketWatch
ECB's quantitative easing plan shaping up
MADRID (MarketWatch) -- U.S. stock futures pointed to a higher open for Wall Street on Monday, shaking off another sharp decline for oil prices as investors ready for a busy week of data and the kickoff to the earnings season with Alcoa Inc.
Reports that the European Central Bank's bond-buying plan is taking shape rallied stocks in Europe.
Acorda Therapeutics, Inc. (Nasdaq: ACOR )
today announced that AMPYRA ® (dalfampridine) Extended Release
Tablets, 10 mg unaudited net sales for the fourth quarter of 2014 were
$109 million, and unaudited AMPYRA 2014 full-year net sales were $366
million, an increase of approximately 21% from 2013.
Fourth Quarter Revenue Increases 11.3% to $92.8 Million Full Year 2014 Revenue of $345.4 Million Represents 11.1% Growth Fourth Quarter Extremities Revenue Grew 16.0% in Constant Currency Over Prior Year
AMSTERDAM, The Netherlands, Jan.
JOHANNESBURG, SOUTH AFRICA--(Marketwired - January 12, 2015) - Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS)(JSE: NT1) ("Net1") today announced it will release second quarter 2015 results after the market close on February 5, 2015.
Dollar Tree, Inc. (NASDAQ:DLTR), the nation's leading operator of
discount variety stores selling everything for $1 or less, today
provided the following update regarding the status of the Federal Trade
Commission’s (the “FTC”) review of its pending acquisition (the “Pending
Merger”) of Family Dollar Stores, Inc. (NYSE: FDO) (“Family Dollar”).
FTC’s Review of the Pending Merger
Dollar Tree and Family Dollar have remained actively engaged with the
staff of the FTC regarding its review of the Pending Merger.
Sign-up for Celebrating National Hot Tea Month, Teavana Invites Customers to Participate in a Green Tea Tasting Journey and Receive a Free Handcrafted Winterberry Green Tea Beverage January 17 investment picks
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.